Monolysocardiolipin acyltransferase: Difference between revisions
Jump to navigation
Jump to search
imported>JCW-CleanerBot m (→Activity during apoptosis: task, replaced: Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire → Biochemistry and Cell Biology) |
|||
| Line 1: | Line 1: | ||
{{Infobox protein | {{Infobox protein | ||
| name = | | name = [[HADHA|Trifunctional enzyme subunit alpha, mitochondrial]] | ||
| image = | | image = | ||
| width = | | width = | ||
| caption = | | caption = | ||
| Symbol = MLCL AT-1 | | Symbol = [[HADHA]] | ||
| AltSymbols = MLCL AT-1 | |||
| IUPHAR_id = | | IUPHAR_id = | ||
| ATC_prefix = | | ATC_prefix = | ||
| Line 13: | Line 13: | ||
| CAS_supplemental = | | CAS_supplemental = | ||
| DrugBank = | | DrugBank = | ||
| EntrezGene = | | EntrezGene = 3030 | ||
| HGNCid = | | HGNCid = 4801 | ||
| OMIM = | | OMIM = 600890 | ||
| PDB = | | PDB = | ||
| RefSeq = | | RefSeq = NP_000173 | ||
| UniProt = | | UniProt = P40939 | ||
| ECnumber = | | ECnumber = 4.2.1.17 | ||
| Chromosome = 2 | | Chromosome = 2 | ||
| Arm = p | | Arm = p | ||
| Line 28: | Line 28: | ||
==History== | ==History== | ||
In 1990, biologists Michael Schlame and Bernd Rustow observed the deacylation of cardiolipin into MLCL, which was then converted back into cardiolipin by a protein using [[Linoleic acid|linoleoyl]] [[coenzyme A]], derived from [[phosphatidylcholine]].<ref name="Schlame1990">{{cite journal| | In 1990, biologists Michael Schlame and Bernd Rustow observed the deacylation of cardiolipin into MLCL, which was then converted back into cardiolipin by a protein using [[Linoleic acid|linoleoyl]] [[coenzyme A]], derived from [[phosphatidylcholine]].<ref name="Schlame1990">{{cite journal | vauthors = Schlame M, Rüstow B | title = Lysocardiolipin formation and reacylation in isolated rat liver mitochondria | journal = The Biochemical Journal | volume = 272 | issue = 3 | pages = 589–95 | date = December 1990 | pmid = 2268287 | pmc = 1149749 | doi = 10.1042/bj2720589 }}</ref> However, acyltransferase activities involved in the reacylation of MLCL had not been identified or characterized in any mammalian tissue until 1999, by the Hatch lab at the [[University of Manitoba]], in [[rat]] [[heart]] mitochondria.<ref name="Ma1999">{{cite journal | vauthors = Ma BJ, Taylor WA, Dolinsky VW, Hatch GM | title = Acylation of monolysocardiolipin in rat heart | journal = Journal of Lipid Research | volume = 40 | issue = 10 | pages = 1837–45 | date = October 1999 | pmid = 10508203 }}</ref> In 2003, the same lab purified and characterized an MLCL acyltransferase in [[pig]] [[liver]] mitochondria,<ref name="Wa2003">{{cite journal | vauthors = Taylor WA, Hatch GM | title = Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria | journal = The Journal of Biological Chemistry | volume = 278 | issue = 15 | pages = 12716–21 | date = April 2003 | pmid = 12569106 | doi = 10.1074/jbc.M210329200 }}</ref> and by comparing this protein against a human protein database, they identified a [[sequencing|sequenced]] but uncharacterized human protein as the enzyme responsible in 2009.<ref name="Taylor2009">{{cite journal | vauthors = Taylor WA, Hatch GM | title = Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1) | journal = The Journal of Biological Chemistry | volume = 284 | issue = 44 | pages = 30360–71 | date = October 2009 | pmid = 19737925 | pmc = 2781591 | doi = 10.1074/jbc.M109.048322 }}</ref> | ||
==Function== | == Function == | ||
MLCL AT-1 catalyzes the transfer of the [[fatty acid]] chain attached to a coenzyme A molecule to an available [[hydroxyl]] group on MLCL, producing cardiolipin. This lipid remodeling is separate from the cardiolipin synthesis pathway, and is essential to maintain its unique [[Saturated and unsaturated compounds|unsaturated]] fatty acyl composition. MLCL AT-1 typically utilizes linoleoyl coenzyme A, preferred to [[Oleic acid|oleoyl]] coenzyme A, which is preferred to [[Palmitic acid|palmitoyl]] coenzyme A.<ref name="Taylor2009" /> | MLCL AT-1 catalyzes the transfer of the [[fatty acid]] chain attached to a coenzyme A molecule to an available [[hydroxyl]] group on MLCL, producing cardiolipin. This lipid remodeling is separate from the cardiolipin synthesis pathway, and is essential to maintain its unique [[Saturated and unsaturated compounds|unsaturated]] fatty acyl composition. MLCL AT-1 typically utilizes linoleoyl coenzyme A, preferred to [[Oleic acid|oleoyl]] coenzyme A, which is preferred to [[Palmitic acid|palmitoyl]] coenzyme A.<ref name="Taylor2009" /> | ||
==Activity during | ==Activity during apoptosis== | ||
MLCL AT-1 activity increases in cells cardiac [[myoblast]] cells exposed to [[2-deoxyglucose]]-induced [[apoptosis]].<ref name="DanosTaylor2008">{{cite journal | vauthors = Danos M, Taylor WA, Hatch GM | title = Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis | journal = Biochemistry and Cell Biology | volume = 86 | issue = 1 | pages = 11–20 | date = February 2008 | pmid = 18364741 | doi = 10.1139/O07-156 }}</ref> MLCL AT-1 activity also increass in a rat model of spontaneously hypertensive [[heart failure]].<ref name="Saini-ChohanHolmes2008">{{cite journal | vauthors = Saini-Chohan HK, Holmes MG, Chicco AJ, Taylor WA, Moore RL, McCune SA, Hickson-Bick DL, Hatch GM, Sparagna GC | title = Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure | journal = Journal of Lipid Research | volume = 50 | issue = 8 | pages = 1600–8 | date = August 2009 | pmid = 19001357 | doi = 10.1194/jlr.M800561-JLR200 | pmc = 2724040 }}</ref> Since cardiolipin content is significantly diminished in the [[inner mitochondrial membrane]] during apoptosis, the increase of lipid remodeling by MLCL AT-1 may be an effort of the cell to maintain normal cardiolipin levels. | |||
==Similarity to | ==Similarity to mitochondrial trifunctional protein== | ||
MLCL AT-1 is completely identical to the 59-kDa [[C-terminal]] end of [[mitochondrial trifunctional protein]] [[HADHA]], suggesting the possibility that the two proteins may be the product of [[alternative splicing]] of the same gene.<ref name="Taylor2009" /> MLCL AT-1 is likely a splice variant of the [[HADHA|alpha subunit]] of MTP.<ref name="BehTaylor2012">{{cite journal | vauthors = Taylor WA, Mejia EM, Mitchell RW, Choy PC, Sparagna GC, Hatch GM | title = Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation | journal = PLOS One | volume = 7 | issue = 11 | pages = e48628 | year = 2012 | pmid = 23152787 | pmc = 3494688 | doi = 10.1371/journal.pone.0048628 }}</ref> | |||
==Hormone | ==Hormone interaction== | ||
Treatment with [[thyroxine]], a [[thyroid hormone]], can produce an almost two-fold increase in MLCL AT-1 activity.<ref>{{cite journal | vauthors = Mutter T, Dolinsky VW, Ma BJ, Taylor WA, Hatch GM | title = Thyroxine regulation of monolysocardiolipin acyltransferase activity in rat heart | journal = The Biochemical Journal | volume = 346 Pt 2 | issue = 2 | pages = 403–6 | date = March 2000 | pmid = 10677359 | doi = 10.1042/0264-6021:3460403 | pmc = 1220866 }}</ref> | |||
==References== | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Enzymes]] | [[Category:Enzymes]] | ||
Latest revision as of 16:44, 28 October 2018
| Trifunctional enzyme subunit alpha, mitochondrial | |
|---|---|
| Identifiers | |
| Symbol | HADHA |
| Alt. symbols | MLCL AT-1 |
| Entrez | 3030 |
| HUGO | 4801 |
| OMIM | 600890 |
| RefSeq | NP_000173 |
| UniProt | P40939 |
| Other data | |
| EC number | 4.2.1.17 |
| Locus | Chr. 2 p23.3 |
Monolysocardiolipin acyltransferase (MLCL AT-1) is a mitochondrial acyltransferase that facilitates the remodeling of monolysocardiolipin (MLCL) into cardiolipin.
History
In 1990, biologists Michael Schlame and Bernd Rustow observed the deacylation of cardiolipin into MLCL, which was then converted back into cardiolipin by a protein using linoleoyl coenzyme A, derived from phosphatidylcholine.[1] However, acyltransferase activities involved in the reacylation of MLCL had not been identified or characterized in any mammalian tissue until 1999, by the Hatch lab at the University of Manitoba, in rat heart mitochondria.[2] In 2003, the same lab purified and characterized an MLCL acyltransferase in pig liver mitochondria,[3] and by comparing this protein against a human protein database, they identified a sequenced but uncharacterized human protein as the enzyme responsible in 2009.[4]
Function
MLCL AT-1 catalyzes the transfer of the fatty acid chain attached to a coenzyme A molecule to an available hydroxyl group on MLCL, producing cardiolipin. This lipid remodeling is separate from the cardiolipin synthesis pathway, and is essential to maintain its unique unsaturated fatty acyl composition. MLCL AT-1 typically utilizes linoleoyl coenzyme A, preferred to oleoyl coenzyme A, which is preferred to palmitoyl coenzyme A.[4]
Activity during apoptosis
MLCL AT-1 activity increases in cells cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis.[5] MLCL AT-1 activity also increass in a rat model of spontaneously hypertensive heart failure.[6] Since cardiolipin content is significantly diminished in the inner mitochondrial membrane during apoptosis, the increase of lipid remodeling by MLCL AT-1 may be an effort of the cell to maintain normal cardiolipin levels.
Similarity to mitochondrial trifunctional protein
MLCL AT-1 is completely identical to the 59-kDa C-terminal end of mitochondrial trifunctional protein HADHA, suggesting the possibility that the two proteins may be the product of alternative splicing of the same gene.[4] MLCL AT-1 is likely a splice variant of the alpha subunit of MTP.[7]
Hormone interaction
Treatment with thyroxine, a thyroid hormone, can produce an almost two-fold increase in MLCL AT-1 activity.[8]
References
- ↑ Schlame M, Rüstow B (December 1990). "Lysocardiolipin formation and reacylation in isolated rat liver mitochondria". The Biochemical Journal. 272 (3): 589–95. doi:10.1042/bj2720589. PMC 1149749. PMID 2268287.
- ↑ Ma BJ, Taylor WA, Dolinsky VW, Hatch GM (October 1999). "Acylation of monolysocardiolipin in rat heart". Journal of Lipid Research. 40 (10): 1837–45. PMID 10508203.
- ↑ Taylor WA, Hatch GM (April 2003). "Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria". The Journal of Biological Chemistry. 278 (15): 12716–21. doi:10.1074/jbc.M210329200. PMID 12569106.
- ↑ 4.0 4.1 4.2 Taylor WA, Hatch GM (October 2009). "Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1)". The Journal of Biological Chemistry. 284 (44): 30360–71. doi:10.1074/jbc.M109.048322. PMC 2781591. PMID 19737925.
- ↑ Danos M, Taylor WA, Hatch GM (February 2008). "Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis". Biochemistry and Cell Biology. 86 (1): 11–20. doi:10.1139/O07-156. PMID 18364741.
- ↑ Saini-Chohan HK, Holmes MG, Chicco AJ, Taylor WA, Moore RL, McCune SA, Hickson-Bick DL, Hatch GM, Sparagna GC (August 2009). "Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure". Journal of Lipid Research. 50 (8): 1600–8. doi:10.1194/jlr.M800561-JLR200. PMC 2724040. PMID 19001357.
- ↑ Taylor WA, Mejia EM, Mitchell RW, Choy PC, Sparagna GC, Hatch GM (2012). "Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation". PLOS One. 7 (11): e48628. doi:10.1371/journal.pone.0048628. PMC 3494688. PMID 23152787.
- ↑ Mutter T, Dolinsky VW, Ma BJ, Taylor WA, Hatch GM (March 2000). "Thyroxine regulation of monolysocardiolipin acyltransferase activity in rat heart". The Biochemical Journal. 346 Pt 2 (2): 403–6. doi:10.1042/0264-6021:3460403. PMC 1220866. PMID 10677359.